Sign up to save your podcasts
Or
Share A closer look at pharma's top R&D budgets
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A closer look at pharma's top R&D budgets
In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fierce Biotech, ranking the top 10 R&D budgets from 2024.
Did Merck hold on to its 2023 crown? And did any new faces crack this year’s list? Listen to find out!
To learn more about the topics in this episode:
- The top 10 pharma R&D budgets for 2024
This week's episode is brought to you by Cencora.
See omnystudio.com/listener for privacy information.
View all episodes
By Fierce Life Sciences
3.8
88 ratings
In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fierce Biotech, ranking the top 10 R&D budgets from 2024.
Did Merck hold on to its 2023 crown? And did any new faces crack this year’s list? Listen to find out!
To learn more about the topics in this episode:
- The top 10 pharma R&D budgets for 2024
This week's episode is brought to you by Cencora.
See omnystudio.com/listener for privacy information.
More shows like The Top Line
View all
WSJ Your Money Briefing
1,714 Listeners
The McKinsey Podcast
389 Listeners
a16z Podcast
1,071 Listeners
Exchanges
965 Listeners
Odd Lots
1,918 Listeners
Macro Musings with David Beckworth
378 Listeners
The Long Run with Luke Timmerman
124 Listeners
The Readout Loud
323 Listeners
Inside the Strategy Room
169 Listeners
Why It Matters
865 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
32 Listeners
Raising Health
145 Listeners
Biotech Hangout
17 Listeners
Ground Truths
51 Listeners